The DETECT V-study – Comparison of dual HER2-targeted therapy with trastuzumab plus pertuzumab in combination with chemo- or endocrine therapy in patients with HER2-positive and hormone-receptor positive metastatic breast cancer

Authors :: Friedl, TWP
Schramm, A
Aktas, B
Müller, V
Rack, B
Fehm, T
Pantel, K
Hartkopf, A
Wimberger, Pauline
Tzschaschel, M
Trapp, E
Schneeweiss, A
Meier-Stiegen, F
Taran, F-A
Janni, W
Fasching, PA
Polasik, A
Publication Year :: 2017

Tools